Pharmacogenetics Associated With IV Ketamine

Participants who previously received intravenous ketamine for treatment-resistant depression provide two saliva swabs for genetic analysis; the study examines associations between genetic markers and clinical response to IV ketamine.

Observational, prospective design leveraging clinic-treated patients at the Canadian Rapid Treatment Centre of Excellence; outcomes are biomarker–response correlations rather than interventional efficacy.